Company page

Scynexis, Inc.

Scynexis, Inc. is a public company traded under the ticker SCYX in the American market, with a market capitalization of approximately $40.2 million. The company focuses on developing innovative therapies for difficult-to-treat infections. Its commitment to addressing unmet medical needs positions it as a key player in the healthcare sector.